VC firm
Harbright Ventures
Also known as Harbright 2023 SonoVascular Series a series of Harbright, Harbright 2023 SonoVascular Series, a series of Harbright LLC, Harbright 2024 SonoVascular Series a series of Harbright, Harbright 2024 SonoVascular Series, a series of Harbright LLC, Harbright 2025 Materna Series a series of Harbright, Harbright 2025 Materna Series, a series of Harbright LLC, Harbright Ventures II LP NC
- Investor type
- VC
- Investing status
- Activeas of 2026-09-22Source (opens in a new tab)
- Headquarters
- CARY, NC, United States
- Latest fund size
- $245KSEC amount sold, vintage 2024
- Funds
- 4
- Legal name
- Harbright Ventures, LLC
- harbrightventures.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Team page (opens in a new tab)
Record updated 29 September 2026
About
Harbright invests in disruptive innovation that positively impacts people and the planet.
Investment approach
- Thesis
- Harbright invests in businesses where our capital base, industry relationships and extensive network of strategic advisors significantly strengthen a company’s outlook and enhance value.Source (opens in a new tab)
- Takes board seats
- Yes
- Board policy
- His board involvement includes serving on the board of Flux Hybrids, previously on the board of Chekhub, and as an observer for SonoVascular.
- Investing status notes
- Apply for Investment
Funds
- Harbright 2025 Materna Series, a series of Harbright LLC
- $25KVintage 2025, SPV, SEC amount sold
- Harbright 2024 SonoVascular Series, a series of Harbright LLC
- $245KVintage 2024, Main fund, SEC amount sold
- Harbright 2023 SonoVascular Series, a series of Harbright LLC
- $451KVintage 2023, Main fund, SEC amount sold
- Harbright Ventures II, LP /NC
- $850KVintage 2022, Main fund, SEC amount sold
SEC registration
- SEC CIK
- 1961721, 2002802, 2021997